“Nothing went to waste; everything that could be used, reused, or repurposed was.” Such was life on the family farm, recalls Navin Norling. Growing up in Oakland, California, the multimodal artist ...
KENNEWICK, Wash., March 3, 2026 /PRNewswire/ -- Columbia Basin Ice LLC, in partnership with Oregon Ice LLC, today announced the successful acquisition of select manufacturing, distribution, and ...
(FOX40.COM) — Navin Khanna pleaded guilty to conspiracy to transport stolen property interstate, conspiracy to commit promotional money laundering and interstate transportation of stolen property on ...
Reddy Ice, a portfolio company of SCI Capital Partners LP, agreed to buy Arctic Glacier from Carlyle Group. The companies announced the deal on the same day that the Justice Department's antitrust ...
ISLE OF PALMS — After a judge ordered an unpermitted seawall in front of a beachfront home must be removed, all parties involved in the litigation are attempting to appeal the ruling. South Carolina ...
Some big-name stars are headed to France to check into "The White Lotus." But their vacation there will surely be far from relaxing. They join previously announced cast members Steve Coogan, Caleb ...
Dr. Reddy's Laboratories (RDY) on Wednesday announced that India’s drug regulator, the Drugs Controller General of India, has issued marketing and manufacturing authorization for a generic version of ...
HYDERABAD, Jan 21 (Reuters) - Indian drugmaker Dr Reddy's (REDY.NS), opens new tab, which reported a smaller-than-expected fall in quarterly profit on Wednesday, said that it has received an approval ...
Navin is a founding partner of CMG Companies, A Dallas based, privately held multi-unit operator of franchised and licensed consumer brands. Prior to joining CMG, he spent 20 years as an operating ...
ISLE OF PALMS — A South Carolina judge has again directed two beachfront property homeowners to remove a seawall they constructed behind their house. A month after S.C. Administrative Law Judge Ralph ...
Dr. Reddy’s Laboratories is paying $20 million upfront for the rights to Immutep’s phase 3-stage LAG-3 candidate in certain territories while leaving the Australian biotech with ownership in key ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results